Related Experiment Video
Updated: Feb 3, 2026

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
[What is established in cell therapies? : Possibilities and limits in immuno-oncology]
1Fraunhofer-Institut für Zelltherapie und Immunologie, Perlickstr. 1, 04103, Leipzig, Deutschland.
Abstract:
Cell and gene therapy as part of immuno-oncology has reached an important milestone in medicine. After decades of experience stem cell transplantation is well established with worldwide >1 million transplantations to date. Due to the improved success of the last years using chimeric antigen receptor (CAR) T cells for CD19 positive leukemia and lymphomas, the interest in cellular therapies is continuously increasing. The current review also gives a short overview about donor lymphocytes, antigen-specific T cells, regulatory T cells, natural killer (NK) cells, mesenchymal stromal cells and induced pluripotent stem (iPS) cells in immuno-oncology.
More Related Videos
Related Concept Videos
Limiting Reactant
The Number e as a Limit
Gene Therapy
Types of Limits I
Limit Laws I
Limits at Infinity

